Corcept Therapeutics Incorporated (CORT)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, Corcept Therapeutics Incorporated has not disclosed its Days of Sales Outstanding (DSO) for the years 2020, 2021, 2022, 2023, and 2024. DSO is a measure of the average number of days a company takes to collect revenue after a sale has been made. Without specific DSO figures, it is challenging to assess the efficiency of Corcept's accounts receivable management and the speed at which it collects cash from its customers. Monitoring DSO can provide insights into a company's cash flow cycle and the effectiveness of its credit and collection policies.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
Corcept Therapeutics Incorporated
CORT
—
Abbott Laboratories
ABT
—
AbbVie Inc
ABBV
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
90.15
Amphastar P
AMPH
67.96
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
7.07
Biomarin Pharmaceutical Inc
BMRN
84.73
Bristol-Myers Squibb Company
BMY
81.21
Catalyst Pharmaceuticals Inc
CPRX
—